New Delhi. Bharat Biotech, which manufactures Covaxin to protect against corona virus, has issued its statement in public interest regarding the safety of the vaccine. After questions were raised on EstroZeneca and Covishield in India, Covaxin manufacturing company Bharat Biotech claimed that there is no risk of blood clotting, thrombocytomania, TTS, YTT, pericarditis, myocarditis from our corona vaccine. Bharat Biotech said that safety comes first for us. The company said that Covaxin is the only vaccine of ours, which was tested in India.
FIRST PUBLISHED: May 2, 2024, 19:39 IST